2019 Scientific Sessions

TAVR Now: Changing How We Treat Aortic Valve Disease

This satellite symposium will use a combination of literature review and case-based presentations to offer a critical review of the available data on TAVR in low surgical risk patients with severe symptomatic aortic stenosis. A preview of upcoming data and a discussion of specific considerations related to this patient subset will be included.
TAVR Hemodynamics Post-implantation: Is ECHO Enough?
Amr E. Abbas, M.D., FSCAI, Beaumont Health, Royal Oak, MI
Shared Decision-Making: What is it Really?
Megan Coylewright, M.D., FSCAI, Dartmouth-Hitchcock Medical Center, Lebanon, NH
See more of: Satellite Sessions